Form 8-K · Current report
TransDigm Group 8-K, filed Sep 21, 2026
- Filed
- CIK
- 0001260221
- Accession no.
- 0001260221-26-000062
Summary
TransDigm Group announced that its operating unit Extant Aerospace signed a definitive agreement to acquire assets comprising a portfolio of commercial rotorcraft, land systems, and business jet products, including a California facility, for about $240 million in cash. The acquisition is expected to close in TransDigm's fiscal year 2027, subject to regulatory approvals and customary closing conditions.
Key points
- Extant Aerospace entered a definitive agreement to acquire assets including a portfolio of commercial rotorcraft, land systems, and business jet products plus a California facility.
- The purchase price is approximately $240 million in cash.
- TransDigm Group said it is disclosing the deal because of the total transaction value, though it does not typically disclose operating-unit asset acquisitions.
- Closing is expected in fiscal year 2027, subject to regulatory approvals and customary conditions.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
From the filing
Item 8.01. Other Events. On September 21, 2026, TransDigm Group Incorporated (“TransDigm Group”) announced that its operating unit, Extant Aerospace, entered into a definitive agreement to acquire certain assets comprising a portfolio of commercial rotorcraft, land systems, and business jet products, including a facility located in California for approximately $240 million in cash (the “Acquisition”). Although TransDigm Group does not typically disclose asset acquisitions by its operating units, TransDigm Group is disclosing the Acquisition based on the total value of the transaction. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.